Management of Deviations & Violations Training Materials available.
ACCORD: Bursaries for patient and public involvement in research
MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others.
A class 2 medicine recall – action within 48 hours – has now been issued by the MHRA for Magnevist (Bayer plc) and Omniscan Solution (GE Healthcare).
Update to IRAS, the Integrated Research Application System, will introduce a single, e-submission of IRAS Forms and associated documents.
The Association of British Insurers (ABI) have confirmed to the Health Research Authority that participation in clinical trials does not affect eligibility criteria for travel insurance and have now withdrawn their guidance document “Clinical research trials and insurance”.
Setting up NHS/HSC research in the UK: A UK Local Information Pack will be introduced on 5th of June 2019
UK Local Information Pack - preparing for change on 5 June 2019 *SLIDES AVAILABLE*
The Health Research Authority (HRA) in association with the devolved administrations, has launched a consultation on research transparency. Last year the organisation was tasked by the House of Commons Science and Technology Committee to devise a new strategy to ensure that trusted information about health and social care research studies is publicly available for the benefit of all.
Setting up NHS / HSC research in the UK– preparing for change on 5 June 2019